Roger D Kamm

Prof. Roger D Kamm

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
IZIoannis K. Zervantonakis
Ioannis K. Zervantonakis
SHShannon K. Hughes-Alford
Shannon K. Hughes-Alford
JCJoseph L. Charest
Joseph L. Charest
JCJohn S. Condeelis
John S. Condeelis
FGFrank B. Gertler
Frank B. Gertler
RKRoger D Kamm
Roger D Kamm
Entry of tumor cells into the blood stream is a critical step in cancer metastasis. Although significant progress has been made in visualizing tumor cell motility in vivo, the underlying mechanism of cancer cell intravasation remains largely unknown. We developed a microfluidic-based assay to recreate the tumor-vascular interface in three-dimensions, allowing for high resolution, real-time imaging, and precise quantification of endothelial barrier function. Studies are aimed at testing the hypothesis that carcinoma cell intravasation is regulated by biochemical factors from the interacting cells and cellular interactions with macrophages. We developed a method to measure spatially resolved endothelial permeability and show that signaling with macrophages via secretion of tumor necrosis factor alpha results in endothelial barrier impairment. Under these conditions intravasation rates were increased as validated with live imaging. To further investigate tumor-endothelial (TC-EC) signaling, we used highly invasive fibrosarcoma cells and quantified tumor cell migration dynamics and TC-EC interactions under control and perturbed (with tumor necrosis factor alpha) barrier conditions. We found that endothelial barrier impairment was associated with a higher number and faster dynamics of TC-EC interactions, in agreement with our carcinoma intravasation results. Taken together our results provide evidence that the endothelium poses a barrier to tumor cell intravasation that can be regulated by factors present in the tumor microenvironment.

1 October 2018 in Biomaterials
Verified
Journal Article
Closed access
Marco CampisiMarco Campisi
Marco Campisi
YSYoojin Shin
Yoojin Shin
TOTatsuya Osaki
Tatsuya Osaki
CHCynthia Hajal
Cynthia Hajal
VCValeria Chiono
Valeria Chiono
RKRoger D Kamm
Roger D Kamm

18 December 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JJJessie Jeon
Jessie Jeon
SBSimone Bersini
Simone Bersini
MGMara Gilardi
Mara Gilardi
GDGabriele Dubini
Gabriele Dubini
JCJoseph L. Charest
Joseph L. Charest
RKRoger D Kamm
Roger D Kamm
A key aspect of cancer metastases is the tendency for specific cancer cells to home to defined subsets of secondary organs. Despite these known tendencies, the underlying mechanisms remain poorly understood. Here we develop a microfluidic 3D in vitro model to analyze organ-specific human breast cancer cell extravasation into bone- and muscle-mimicking microenvironments through a microvascular network concentrically wrapped with mural cells. Extravasation rates and microvasculature permeabilities were significantly different in the bone-mimicking microenvironment compared with unconditioned or myoblast containing matrices. Blocking breast cancer cell A3 adenosine receptors resulted in higher extravasation rates of cancer cells into the myoblast-containing matrices compared with untreated cells, suggesting a role for adenosine in reducing extravasation. These results demonstrate the efficacy of our model as a drug screening platform and a promising tool to investigate specific molecular pathways involved in cancer biology, with potential applications to personalized medicine.

7 June 2012 in Nature Protocols
Verified
Journal Article
Open access
PDF file
YSYoojin Shin
Yoojin Shin
SHSewoon Han
Sewoon Han
JJJessie Jeon
Jessie Jeon
KYKyoko Yamamoto
Kyoko Yamamoto
IZIoannis K Zervantonakis
Ioannis K Zervantonakis
SCSeok Chung
Seok Chung
This protocol describes a simple but robust microfluidic assay combining three-dimensional (3D) and two-dimensional (2D) cell culture. The microfluidic platform comprises hydrogel-incorporating chambers between surface-accessible microchannels. By using this platform, well-defined biochemical and biophysical stimuli can be applied to multiple cell types interacting over distances of <1 mm, thereby replicating many aspects of the in vivo microenvironment. Capabilities exist for time-dependent manipulation of flow and concentration gradients as well as high-resolution real-time imaging for observing spatial-temporal single-cell behavior, cell-cell communication, cell-matrix interactions and cell population dynamics. These heterotypic cell type assays can be used to study cell survival, proliferation, migration, morphogenesis and differentiation under controlled conditions. Applications include the study of previously unexplored cellular interactions, and they have already provided new insights into how biochemical and biophysical factors regulate interactions between populations of different cell types. It takes 3 d to fabricate the system and experiments can run for up to several weeks.

1 August 2016 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
FSFabian Spill
Fabian Spill
DRDaniel S Reynolds
Daniel S Reynolds
RKRoger D Kamm
Roger D Kamm
MZMuhammad H Zaman
Muhammad H Zaman

1 March 2014 in Biomaterials
Verified
Journal Article
Open access
SBSimone Bersini
Simone Bersini
JJJessie Jeon
Jessie Jeon
GDGabriele Dubini
Gabriele Dubini
CAChiara Arrigoni
Chiara Arrigoni
SCSeok Chung
Seok Chung
RKRoger D Kamm
Roger D Kamm
Cancer metastases arise following extravasation of circulating tumor cells with certain tumors exhibiting high organ specificity. Here, we developed a 3D microfluidic model to analyze the specificity of human breast cancer metastases to bone, recreating a vascularized osteo-cell conditioned microenvironment with human osteo-differentiated bone marrow-derived mesenchymal stem cells and endothelial cells. The tri-culture system allowed us to study the transendothelial migration of highly metastatic breast cancer cells and to monitor their behavior within the bone-like matrix. Extravasation, quantified 24 h after cancer cell injection, was significantly higher in the osteo-cell conditioned microenvironment compared to collagen gel-only matrices (77.5 ± 3.7% vs. 37.6 ± 7.3%), and the migration distance was also significantly greater (50.8 ± 6.2 μm vs. 31.8 ± 5.0 μm). Extravasated cells proliferated to form micrometastases of various sizes containing 4 to more than 60 cells by day 5. We demonstrated that the breast cancer cell receptor CXCR2 and the bone-secreted chemokine CXCL5 play a major role in the extravasation process, influencing extravasation rate and traveled distance. Our study provides novel 3D in vitro quantitative data on extravasation and micrometastasis generation of breast cancer cells within a bone-like microenvironment and demonstrates the potential value of microfluidic systems to better understand cancer biology and screen for new therapeutics.